Clinical Trials
8 trialsNCT02965703 2026-05-28
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT02521285 2026-04-29
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT02169271 2020-05-21
Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules
National Cancer Institute (NCI)
Phase 2 Completed
NCT00983580 2019-09-04
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT02123849 2018-08-29
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers
National Cancer Institute (NCI)
Phase 2 Completed
NCT00468910 2017-05-31
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00474903 2014-07-02
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00020189 2013-06-19
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Completed